Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior by Chen Zhe-Yu, Jing Deqiang, Bath Kevin G, Ieraci Alessandro, Khan Tanvir, Siao Chia-Jen, Herrera Daniel G, Toth Miklos, Yang Chingwen, McEwen Bruce S, Hempstead Barbara L, Lee Francis S in Science (New York, N.Y.) (2006).

[PMID: 17023662] PubMed


A common single-nucleotide polymorphism in the brain-derived neurotrophic factor (BDNF) gene, a methionine (Met) substitution for valine (Val) at codon 66 (Val66Met), is associated with alterations in brain anatomy and memory, but its relevance to clinical disorders is unclear. We generated a variant BDNF mouse (BDNF(Met/Met)) that reproduces the phenotypic hallmarks in humans with the variant allele. BDNF(Met) was expressed in brain at normal levels, but its secretion from neurons was defective. When placed in stressful settings, BDNF(Met/Met) mice exhibited increased anxiety-related behaviors that were not normalized by the antidepressant, fluoxetine. A variant BDNF may thus play a key role in genetic predispositions to anxiety and depressive disorders.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.